Ascendis Pharma A/S Establishes Oncology as its Second Independent Therapeutic Area; Appoints Juha Punnonen as Senior Vice President and Head of Oncology
To lead the oncology research and development programs, Ascendis recently appointed Juha Punnonen, MD, PhD, as Senior Vice President and Head of Oncology. Dr. Punnonen was most recently an Executive Director, Oncology Discovery Research, at Merck & Co. Inc.